Philippe Morlat

4.8k total citations
65 papers, 2.6k citations indexed

About

Philippe Morlat is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Philippe Morlat has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 32 papers in Virology and 23 papers in Epidemiology. Recurrent topics in Philippe Morlat's work include HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (32 papers) and HIV/AIDS Research and Interventions (25 papers). Philippe Morlat is often cited by papers focused on HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (32 papers) and HIV/AIDS Research and Interventions (25 papers). Philippe Morlat collaborates with scholars based in France, United States and Belize. Philippe Morlat's co-authors include Geneviève Chêne, Catherine Leport, François Dabis, M. Dupon, Charlotte Lewden, Jean‐Louis Vildé, Benjamin J. Luft, D. Neau, Fabrice Bonnet and Jean‐Luc Pellegrin and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Philippe Morlat

64 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Morlat France	27	1.4k	1.1k	1.0k	510	382	65	2.6k
Christophe Piketty France	30	1.6k 1.2×	1.5k 1.4×	1.2k 1.2×	106 0.2×	273 0.7×	116	3.7k
Pompeyo Viciana Spain	31	1.7k 1.2×	1.1k 1.0×	1.2k 1.2×	165 0.3×	408 1.1×	131	2.9k
Keikawus Arastéh Germany	30	1.7k 1.2×	763 0.7×	1.2k 1.2×	77 0.2×	227 0.6×	93	2.8k
M. Dietrich Germany	24	1.1k 0.8×	779 0.7×	963 1.0×	81 0.2×	378 1.0×	70	2.7k
Charles D. Mitchell United States	27	1.3k 1.0×	1.2k 1.1×	511 0.5×	114 0.2×	291 0.8×	80	2.4k
Claudine Duvivier France	30	1.4k 1.0×	1.2k 1.1×	1.0k 1.0×	51 0.1×	569 1.5×	110	2.7k
Luís F. López‐Cortés Spain	29	1.4k 1.0×	1.5k 1.3×	631 0.6×	140 0.3×	316 0.8×	155	2.8k
Jeffrey L. Lennox United States	34	2.7k 2.0×	1.3k 1.2×	1.7k 1.7×	86 0.2×	1.1k 2.8×	83	4.2k
Thierry May France	21	757 0.6×	976 0.9×	330 0.3×	62 0.1×	404 1.1×	40	1.8k
Salvatore Casari Italy	26	807 0.6×	750 0.7×	247 0.2×	86 0.2×	198 0.5×	75	2.1k

Countries citing papers authored by Philippe Morlat

Since Specialization

Citations

This map shows the geographic impact of Philippe Morlat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Morlat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Morlat more than expected).

Fields of papers citing papers by Philippe Morlat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Morlat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Morlat. The network helps show where Philippe Morlat may publish in the future.

Co-authorship network of co-authors of Philippe Morlat

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Morlat. A scholar is included among the top collaborators of Philippe Morlat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Morlat. Philippe Morlat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertine, Mélanie, Gilles Peytavin, Antoine Bachelard, et al.. (2024). Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy With Lenacapavir-containing Regimen. Clinical Infectious Diseases. 81(2). 341–344. 2 indexed citations

Wittkop, Linda, Firouzé Bani‐Sadr, Karine Lacombe, et al.. (2021). Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants. HIV Medicine. 22(9). 791–804. 3 indexed citations

Vandenhende, Marie-Anne, Caroline Roussillon, Sandrine Hénard, et al.. (2015). Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000. PLoS ONE. 10(6). e0129550–e0129550. 64 indexed citations

Hoën, Bruno, Fabrice Bonnet, Constance Delaugerre, et al.. (2014). French 2013 guidelines for antiretroviral therapy of HIV‐1 infection in adults. Journal of the International AIDS Society. 17(1). 19034–19034. 36 indexed citations

Boulet, Thomas, Juliette Pavie, Isabelle Charreau, et al.. (2010). Impact on Health-Related Quality of Life of a Switch From Enfuvirtide to Raltegravir Among Multidrug-Resistant HIV-1–Infected Patients: A Randomized Open-Label Trial (EASIER-ANRS 138). HIV Clinical Trials. 11(5). 283–293. 8 indexed citations

Wesenbeeck, Liesbeth Van, Dominique Breilh, Guerric Anies, et al.. (2010). HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. Journal of Antimicrobial Chemotherapy. 65(6). 1262–1269. 54 indexed citations

Piroth, Lionel, Stanislas Pol, Karine Lacombe, et al.. (2010). Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: The EPIB 2008 study. Journal of Hepatology. 53(6). 1006–1012. 37 indexed citations

Bonnet, Fabrice, Christine Burty, Charlotte Lewden, et al.. (2009). Changes in Cancer Mortality among HIV‐Infected Patients: The Mortalité 2005 Survey. Clinical Infectious Diseases. 48(5). 633–639. 122 indexed citations

Bouldouyre, Marie‐Anne, Isabelle Charreau, B. Marchou, et al.. (2009). Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(5). 531–537. 11 indexed citations

10.

Rosenthal, Éric, Dominique Salmon‐Céron, Charlotte Lewden, et al.. (2009). Liver‐related deaths in HIV‐infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalité 2005 survey, ANRS EN19)^*. HIV Medicine. 10(5). 282–289. 78 indexed citations

11.

Morlat, Philippe, Edwige Pereira, Pascal Clayette, et al.. (2008). Early Evolution of Plasma Soluble TNF- α p75 Receptor as a Marker of Progression in Treated HIV-Infected Patients. AIDS Research and Human Retroviruses. 24(11). 1383–1389. 6 indexed citations

12.

Lewden, Charlotte, Geneviève Chêne, Philippe Morlat, et al.. (2007). HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term Combination Antiretroviral Therapy Reach Same Mortality Rates as the General Population. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(1). 72–77. 305 indexed citations

13.

Bonnet, Fabrice, M. Bonarek, P. Mercié, et al.. (2003). Acidose lactique sévère chez les patients infectés par le VIH traités par inhibiteurs nucléosidiques de la reverse transcriptase : 9 cas. La Revue de Médecine Interne. 24(1). 11–16. 11 indexed citations

14.

Bonnet, Fabrice, S. Lawson‐Ayayi, Rodolphe Thiébaut, et al.. (2002). A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999. Clinical Infectious Diseases. 35(10). 1231–1237. 41 indexed citations

15.

Chêne, Geneviève, Philippe Morlat, Richard Hafner, et al.. (1998). Intention-to-Treat vs. On-Treatment Analyses of Clinical Trial Data. Controlled Clinical Trials. 19(3). 233–248. 39 indexed citations

16.

Dabis, François, M. Dupon, D. Lacoste, et al.. (1996). Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. BMJ. 313(7055). 461–464. 45 indexed citations

17.

Morlat, Philippe, et al.. (1993). Toxoplasmose cérébrale au cours du SIDA. 73 observations. Groupe d'Epidémiologie clinique su SIDA en Aquitaine.. La Presse Médicale. 22(19). 1 indexed citations

18.

Luft, Benjamin J., Richard Hafner, Ann H. Korzun, et al.. (1993). Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 329(14). 995–1000. 293 indexed citations

19.

Roithmann, Sérgio, Michel Toledano, J.M. Tourani, et al.. (1991). HIV-associated non-Hodgkin's lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated Tumors*. Annals of Oncology. 2(4). 289–295. 39 indexed citations

20.

Msellati, Philippe, M. Dupon, Philippe Morlat, D. Lacoste, & Jean‐Luc Pellegrin. (1990). A cohort study of 89 HIV-1 -infected adult patients contaminated by blood products. AIDS. 4(11). 1105–1110. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact